Cas:57-92-1 streptomycin manufacturer & supplier

Chemical Name:streptomycin

CAS.NO:57-92-1

Synonyms:Agrept;Neodiestreptopab;Streptomycin;streptomicina;N,N’-[(1R,2R,3S,4R,5R,6S)-4-[[5-deoxy-2-O-[2-deoxy-2-(methylamino)-α-L-glucopyranosyl]-3-C-formyl-α-L-lyxofuranosyl]oxy]-2,5,6-trihydroxy-1,3-cyclohexanediyl]bis[guanidine];O-2-deoxy-2-methylamino-α-L-glucopyranosyl-(1→2)-O-5-deoxy-3-C-formyl-α-L-lyxofuranosyl-(1→4)-N1,N3-diamidino-D-streptamine;STREPTOMYCIN A;1,1’-{1-D-(1,3,5/2,4,6)-4-[5-deoxy-2-O-(2-deoxy-2-methylamino-α-L-glucopyranosyl)-3-C-formyl-α-L-lyxofuranosyloxy]-2,5,6-trihydroxycyclohex-1,3-ylene}diguanidine;8th edition;Agrimycin

Molecular Formula:C₂₁H₃₉N₇O₁₂

Molecular Weight:581.574

HS Code:2941200000

Physical and Chemical Properties:

Melting point:N/A

Boiling point:872.9±75.0 °C at 760 mmHg

Density:2.0±0.1 g/cm3

Index of Refraction:1.762

PSA:331.43000

Exact Mass:581.265686

LogP:-2.53

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Agrept chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Agrimycin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Streptomycin Use and application,N,N’-[(1R,2R,3S,4R,5R,6S)-4-[[5-deoxy-2-O-[2-deoxy-2-(methylamino)-α-L-glucopyranosyl]-3-C-formyl-α-L-lyxofuranosyl]oxy]-2,5,6-trihydroxy-1,3-cyclohexanediyl]bis[guanidine] technical grade,usp/ep/jp grade.

Related News: The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD. streptomycin manufacturer The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population. streptomycin supplier The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD. streptomycin vendor As the global generic drug market booms and the international API industry accelerates its transfer to developing countries, China and India rely on cost advantages to rapidly grow into major API producers and exporters. streptomycin factory The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD.